Cargando…
Major adverse cardiovascular events in people with chronic kidney disease in relation to disease severity and diabetes status
Diabetes plays an important role in the complex relationship between chronic kidney disease (CKD) and cardiovascular disease. This retrospective observational study compared the influence of estimated glomerular filtration rate (eGFR) and proteinuria on the risk of major adverse cardiovascular event...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6713399/ https://www.ncbi.nlm.nih.gov/pubmed/31461449 http://dx.doi.org/10.1371/journal.pone.0221044 |
_version_ | 1783446869895020544 |
---|---|
author | Currie, Craig J. Berni, Ellen R. Berni, Thomas R. Jenkins-Jones, Sara Sinsakul, Marvin Jermutus, Lutz Ambery, Philip Jain, Meena |
author_facet | Currie, Craig J. Berni, Ellen R. Berni, Thomas R. Jenkins-Jones, Sara Sinsakul, Marvin Jermutus, Lutz Ambery, Philip Jain, Meena |
author_sort | Currie, Craig J. |
collection | PubMed |
description | Diabetes plays an important role in the complex relationship between chronic kidney disease (CKD) and cardiovascular disease. This retrospective observational study compared the influence of estimated glomerular filtration rate (eGFR) and proteinuria on the risk of major adverse cardiovascular event (MACE; myocardial infarction or stroke) in CKD patients with and without diabetes. Data were from a linked database of UK electronic health records. Individuals with CKD and no prior MACE were classified as type 1 diabetes (T1DM; n = 164), type 2 diabetes (T2DM; n = 9,711), and non-diabetes (non-DM; n = 75,789). Monthly updated time-dependent Cox proportional hazard models were constructed to calculate adjusted hazard ratios (aHRs) for progression to MACE from first record of abnormal eGFR or proteinuria (index date). In non-DM, aHRs (95% CIs) by baseline eGFR category (referent G2) were G1: 0.70 (0.55–0.90), G3a: 1.28 (1.20–1.35), G3b: 1.64 (1.52–1.76), G4: 2.19 (1.98–2.43), and G5: 3.12 (2.44–3.99), and by proteinuria category (referent A1) were A2: 1.13 (1.00–1.28), A2/3 (severity indeterminable): 1.58 (1.28–1.95), and A3: 1.64 (1.38–1.95). In T2DM, aHRs were G1: 0.98 (0.72–1.32), G3a: 1.18 (1.03–1.34), G3b: 1.31 (1.12–1.54), G4: 1.87 (1.53–2.29), G5: 2.87 (1.82–4.52), A2: 1.22 (1.04–1.42), A2/3: 1.45 (1.17–1.79), and A3: 1.82 (1.53–2.16). Low numbers in T1DM precluded analysis. Modelling T2DM and non-DM together, aHRs were, respectively, G1: 3.23 (2.38–4.40) and 0.70 (0.55–0.89); G2: 3.18 (2.73–3.70) and 1.00 (referent); G3a: 3.65 (3.13–4.25) and 1.28 (1.21–1.36); G3b: 4.01 (3.40–4.74) and 1.65 (1.54–1.77); G4: 5.78 (4.70–7.10) and 2.21 (2.00–2.45); G5: 9.00 (5.71–14.18) and 3.14 (2.46–4.00). In conclusion, reduced eGFR and proteinuria were independently associated with increased risk of MACE regardless of diabetes status. However, the risk of MACE in the same eGFR state was 4.6–2.4 times higher in T2DM than in non-DM. |
format | Online Article Text |
id | pubmed-6713399 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-67133992019-09-04 Major adverse cardiovascular events in people with chronic kidney disease in relation to disease severity and diabetes status Currie, Craig J. Berni, Ellen R. Berni, Thomas R. Jenkins-Jones, Sara Sinsakul, Marvin Jermutus, Lutz Ambery, Philip Jain, Meena PLoS One Research Article Diabetes plays an important role in the complex relationship between chronic kidney disease (CKD) and cardiovascular disease. This retrospective observational study compared the influence of estimated glomerular filtration rate (eGFR) and proteinuria on the risk of major adverse cardiovascular event (MACE; myocardial infarction or stroke) in CKD patients with and without diabetes. Data were from a linked database of UK electronic health records. Individuals with CKD and no prior MACE were classified as type 1 diabetes (T1DM; n = 164), type 2 diabetes (T2DM; n = 9,711), and non-diabetes (non-DM; n = 75,789). Monthly updated time-dependent Cox proportional hazard models were constructed to calculate adjusted hazard ratios (aHRs) for progression to MACE from first record of abnormal eGFR or proteinuria (index date). In non-DM, aHRs (95% CIs) by baseline eGFR category (referent G2) were G1: 0.70 (0.55–0.90), G3a: 1.28 (1.20–1.35), G3b: 1.64 (1.52–1.76), G4: 2.19 (1.98–2.43), and G5: 3.12 (2.44–3.99), and by proteinuria category (referent A1) were A2: 1.13 (1.00–1.28), A2/3 (severity indeterminable): 1.58 (1.28–1.95), and A3: 1.64 (1.38–1.95). In T2DM, aHRs were G1: 0.98 (0.72–1.32), G3a: 1.18 (1.03–1.34), G3b: 1.31 (1.12–1.54), G4: 1.87 (1.53–2.29), G5: 2.87 (1.82–4.52), A2: 1.22 (1.04–1.42), A2/3: 1.45 (1.17–1.79), and A3: 1.82 (1.53–2.16). Low numbers in T1DM precluded analysis. Modelling T2DM and non-DM together, aHRs were, respectively, G1: 3.23 (2.38–4.40) and 0.70 (0.55–0.89); G2: 3.18 (2.73–3.70) and 1.00 (referent); G3a: 3.65 (3.13–4.25) and 1.28 (1.21–1.36); G3b: 4.01 (3.40–4.74) and 1.65 (1.54–1.77); G4: 5.78 (4.70–7.10) and 2.21 (2.00–2.45); G5: 9.00 (5.71–14.18) and 3.14 (2.46–4.00). In conclusion, reduced eGFR and proteinuria were independently associated with increased risk of MACE regardless of diabetes status. However, the risk of MACE in the same eGFR state was 4.6–2.4 times higher in T2DM than in non-DM. Public Library of Science 2019-08-28 /pmc/articles/PMC6713399/ /pubmed/31461449 http://dx.doi.org/10.1371/journal.pone.0221044 Text en © 2019 Currie et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Currie, Craig J. Berni, Ellen R. Berni, Thomas R. Jenkins-Jones, Sara Sinsakul, Marvin Jermutus, Lutz Ambery, Philip Jain, Meena Major adverse cardiovascular events in people with chronic kidney disease in relation to disease severity and diabetes status |
title | Major adverse cardiovascular events in people with chronic kidney disease in relation to disease severity and diabetes status |
title_full | Major adverse cardiovascular events in people with chronic kidney disease in relation to disease severity and diabetes status |
title_fullStr | Major adverse cardiovascular events in people with chronic kidney disease in relation to disease severity and diabetes status |
title_full_unstemmed | Major adverse cardiovascular events in people with chronic kidney disease in relation to disease severity and diabetes status |
title_short | Major adverse cardiovascular events in people with chronic kidney disease in relation to disease severity and diabetes status |
title_sort | major adverse cardiovascular events in people with chronic kidney disease in relation to disease severity and diabetes status |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6713399/ https://www.ncbi.nlm.nih.gov/pubmed/31461449 http://dx.doi.org/10.1371/journal.pone.0221044 |
work_keys_str_mv | AT curriecraigj majoradversecardiovasculareventsinpeoplewithchronickidneydiseaseinrelationtodiseaseseverityanddiabetesstatus AT berniellenr majoradversecardiovasculareventsinpeoplewithchronickidneydiseaseinrelationtodiseaseseverityanddiabetesstatus AT bernithomasr majoradversecardiovasculareventsinpeoplewithchronickidneydiseaseinrelationtodiseaseseverityanddiabetesstatus AT jenkinsjonessara majoradversecardiovasculareventsinpeoplewithchronickidneydiseaseinrelationtodiseaseseverityanddiabetesstatus AT sinsakulmarvin majoradversecardiovasculareventsinpeoplewithchronickidneydiseaseinrelationtodiseaseseverityanddiabetesstatus AT jermutuslutz majoradversecardiovasculareventsinpeoplewithchronickidneydiseaseinrelationtodiseaseseverityanddiabetesstatus AT amberyphilip majoradversecardiovasculareventsinpeoplewithchronickidneydiseaseinrelationtodiseaseseverityanddiabetesstatus AT jainmeena majoradversecardiovasculareventsinpeoplewithchronickidneydiseaseinrelationtodiseaseseverityanddiabetesstatus |